Seminars in Neurology

Issue 01 · Volume 33 · February 2013 DOI: 10.1055/s-003-25034 Current and Emerging Therapies for Multiple Sclerosis Guest Editor, B. Mark Keegan, MD, FRCP(C)

Introduction of the Guest Editor

001

Roos, Karen L.: Mark Keegan, MD, FRCP(C)

Full Text
HTML
PDF (31 kb)

Preface

003

Keegan, B. Mark: Current and Emerging Therapies for Multiple Sclerosis

Full Text
HTML
PDF (42 kb)

005

Keegan, B. Mark: Therapeutic Decision Making in a New Drug Era in Multiple Sclerosis

Full Text
HTML
PDF (193 kb)

013

Goodin, Douglas S.: The Use of Interferon Beta and Glatiramer Acetate in Multiple Sclerosis

Full Text
HTML
PDF (211 kb)

026

Derfuss, Tobias; Kuhle, Jens; Lindberg, Raija; Kappos, Ludwig: Natalizumab Therapy for Multiple Sclerosis

Full Text
HTML
PDF (170 kb)

037

Willis, Mary A.; Cohen, Jeffrey A.: Fingolimod Therapy for Multiple Sclerosis

Full Text
HTML
PDF (142 kb)

045

Oh, Jiwon; O'Connor, Paul W.: Teriflunomide for the Treatment of Multiple Sclerosis

Full Text
HTML
PDF (215 kb)

056

Phillips, J. Theodore; Fox, Robert J.: BG-12 in Multiple Sclerosis

Full Text
HTML
PDF (154 kb)

066

Coles, Alasdair J.: Alemtuzumab Treatment of Multiple Sclerosis

Full Text
HTML
PDF (126 kb)

074

Kantarci, Orhun: Treatment of Primary Progressive Multiple Sclerosis

Full Text
HTML
PDF (75 kb)